Live bacterium B. thetaiotaomicron
Key facts
| Active substance |
Live bacterium B. thetaiotaomicron
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/166/2009
|
| PIP number |
Live bacterium B. thetaiotaomicron
|
| Pharmaceutical form(s) |
Live Bacteria in an Enteric Coated Capsule
|
| Condition(s) / indication(s) |
Treatment of Crohn's disease
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
4D Pharma Research Ltd
|
| Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|